Eric Roos Email & Phone Number

Amsterdam Area, Netherlands

Providing advice and support to business leadership teams in Life Sciences business, in the areas of manufacturing, R&D/technology, HR/governance and business (development). Working with large (corporate) as well as SME's.

Woerden, Utrecht, Netherlands

DCRF is a network organisation which aims to create better/optimal conditions for carrying out clinical trials (on new medicines or treatments) in The Netherlands.See also www.dctf.nl

The Royal Dutch Chemical Society is the professional association for chemistry, life sciences, process technology and (bio) molecular science. See also www.kncv.nlDe Koninklijke Nederlandse Chemische Vereniging is de beroepsvereniging voor chemie, life sciences, procestechnologie en (bio)moleculaire wetenschap. De KNCV komt op voor de belangen van haar leden

The Dutch Parkinson Association (Parkinson Vereniging) is an active association which aims to ensure an optimal quality of life for the approx. 40.000 people in The Netherlands who have been diagnosed with Parkinson's disease (or Parkonsonism). Currently it has 9.000 members.see also www.parkinson-vereniging.nlDe Parkinson Vereniging is een actieve vereniging die zich inzet voor een zo goed mogelijke kwaliteit van leven voor alle 40.000 mensen met de ziekte van Parkinson of een Parkinsonisme (*). De rol van partners en kinderen (soms tevens mantelzorger) krijgt ruim aandacht. Er zijn momenteel bijna 9.000 leden en ruim 120 contactgroepen verspreid over het land. Het hoogste orgaan van de vereniging is de Algemene Ledenvergadering die het bestuur controleert. Het bestuur wordt in haar werkzaamheden ondersteund door het verenigingsbureau

HollandBIO is the assocation of biotechnology companies in The Netherlands. Established in November 2013 as a result of a merger between the former branch organisations Niaba and BioFarmind, its aim is to create optimal conditions for conducting biotech-based business and innovation.see also www.hollandbio.nlHollandBIO is de belangenvereniging voor de Nederlandse biotechnologie-industrieDe biotechnologie-industrie levert een belangrijke bijdrage aan een gezonde, duurzame, op hoogwaardige kennis gebaseerde economie en maatschappij. HollandBIO bundelt de krachten van ruim 125 medische, agro-food en industriële- biotechnologie bedrijven en organisaties. Met 1 sterke stem zet HollandBIO zich in voor een optimaal innovatieklimaat zodat de mogelijkheden van de Nederlandse biotechnologie-industrie ten volste benut kunnen worden

NIABA is one of the two biotech-associations which have recently merged into a new, combined association, established under the name HollandBIO. See also above.

Delft Area, Netherlands

BPF is an independent business entity with shareholders and stakeholders from industry, academia and (national, regional and local) governmental organisations. BPF mission is to boost innovation in bio-based economy by providing skills and infrastructure for scaling up on bio-based products and processes.As Director BPF responsibilities were those of a Business Director in a start-up environment a.o.: write a Business Plan for the commercial exploitation of this biotech pilot plant, separation of the assets from DSM, prepare an investment plan for extending the unit and securing governmental subsidies for this, design and start-up of the new entity, transfer of R&D-resources from DSM and hiring of additional people, prepare and execute a marketing & PR-strategy, translate to and execute a sales & account development plan, generate first customers and sales, manage the unit within safety and environmental standards, etc.

Heerlen, Limburg, Netherlands

Initiate a project to come to a new R&D-strategy and goverance model for the R&D-activities in DSM.

Delft Area, Netherlands

DFS is DSM's Business Group that is active in the area of Food Supplements. Its main strategic goal was to be the number 1 supplier in new, innovative food supplements, particularly food enzymes, savoury ingredients (yeast and yeast extracts) and cultures.DBC was/is a Competence Center in biotechnology within DSM, employing approx. 500 scientists and technicians trained in the various disiplines in biotechnology (genetics, fermentation, process technology, biochemistry, analytical chemistry, application, food technology, ...). The DBC is made up by two formerly separate BG-R&D-organisations (DAI and DFS), and started in 2009 as a merged, new entity. Working in highly integrated (project) teams, the DBC strongly contributes to the realisation of DSM's business and innovation goals in the food/nutrition, pharma, industrial biotech and materials sectors. Approximately 50% of the DBC-organisation was allocated/dedicated to R&D-projects for its own BG, DFS. The other 50% of the resources were 'hired in' by other DSM-BG's.Responsibilities as R&D-Director: definition and execution through projects/project managers of an R&D-technology strategy for the total BG as well as its PMC (Product/Market Combination) clusters. Safeguard the R&D-technology function in the BG-Management Team. Translation of the R&D-strategy into a Competence Plan and execution of it, thereby securing access to the required key R&D-competences for the BG.As Director DBC: Management of a line R&D-organisation of approx 500 people, as the core Competence Center for biotechnology in DSM. Ensuring that output targets as agreed with business teams are met and that necessary resources are made available to the R&D-projects/programs of the various BG's within DSM. Buidling/ maintaining a strong external network ao with academic partners.

Delft Area, Netherlands

DSM Anti-Infectives - nowadays named DSM-Sinochem Pharmaceuticals Ltd (DSP) is DSM's Business Group that is active in the anti-infectives generics market (mainly beta-lactam antibiotics = penicillin and penicillin-derived products).Responsibilities as R&D-Director: definition and execution of an R&D-technology strategy for the total BG as well as its PMC (Product/Market Combination) clusters. Safeguard the R&D- and technology function in the BG-Global Management Team. Translation of the R&D-strategy into a Competence Plan and execution of it, thereby securing access to the required key R&D-competences for the BG. Management of a line R&D-organisation of approx 130 people (primarily R&D-scientists and technicians). Participation in a DSM-wide group of BG-R&D-Directors, aligning and optimising the total Competence Development Plan. Build up/maintenance of a strong external network ao with academic partners.Special assignment in 2008: Project Manager for the preparation and implementation of an organisational merger between two formerly separate R&D-units (DAI : approx 130 people; DFS: approx 330 people) into a new entity, the DSM Biotechnology Center (DBC). See also above.

Delft Area, Netherlands

Responsible for the safe, effective and efficient operation of a large fermentation production plant. Realising an output and fixed and variable cost-price as agreed with the Business Team/Management, and at the same time execute the necessary preparations/tests to enable a fast output/productivity growth. Delivering product quality within agreed specifications, and side/waste streams within environmental limits. Operate within very strict safety standards.

Delft Area, Netherlands, Barcelona, Spain; Zibo, Shandong Province, China

As senior R&D-project manager: responsible for building/maintaining/managing a coherent portfolio of feasibility studies and R&D-projects for Semi-Synthetic Cephalosporines (SSC's), aligned with the company's strategy and the mid-term technology/quality/output/cost-price targets of the Business Team (BT) SSC's. Realisation of the set targets for the individual R&D-projects within this program.As International Production Support advisor (IPS-advisor): Support to the manufacturing network/sites for SSC's (Delft, The Netherlands; Barcelona, Spain; Zibo, Shandong Province, China) with regard to technological, technical and operational issues; representation of the manufacturing function and the manufacturing sites in the BT SSC's.

Geleen, The Netherlands

As scientist: development (as scientist) of economically feasible routes for the production of pharmaceutical intermediates for custom manufacturing purposes; identification of novel, feasible, enzymatic production process for semi-synthetic antibiotics (SSA's).As R&D-project manager: successful implementation and start-up of a new, enzymatic process for the production of semi-synthetic cefalexin.

Phd, Organic Chemistry

Msc, Organic Chemistry

Secondary School